Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...

Around 5 days after signing up ... or you can pick it up at your local pharmacy that same day. Wegovy is the first GLP-1 medication with FDA approval for weight loss. The organization gave ...

A breakthrough in weight loss medication is on the horizon. While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more convenient ...

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as potentially alleviate some of the drug's common side effects.

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

Wegovy for weight loss and Ozempic for diabetes, were key to its earnings beat. Combined, they brought in $24.9 billion for the year. That's compared to the 2023 full-year revenue of $18.5 billion.

Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid ...

FILE - A dosage of Wegovy, March 1, 2024 in Front Royal ... thousands — of dollars for 30-day supplies of popular drugs used by millions of people on Medicare. They included popular blood ...